Evidence map›Paper›PMID 34877794›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2022

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment.

Anna Pink, Janina Krell-Roesch, Jeremy A Syrjanen, Maria Vassilaki, Val J Lowe, Prashanthi Vemuri, Gorazd B Stokin, Teresa J Christianson, Walter K Kremers, Clifford R Jack and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Associations between joint air pollution exposure, mental health, and physical health and dementia incidence in an aging U.S. cohort.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Specific Association of Worry With Amyloid-β But Not Tau in Cognitively Unimpaired Older Adults.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Anna PinkDepartment of Geriatrics, Paracelsus Medical University, Salzburg, Austria.
Janina Krell-RoeschDepartment of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Jeremy A SyrjanenDepartment of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Maria VassilakiDepartment of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Val J LoweDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Prashanthi VemuriDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Gorazd B StokinInternational Clinical Research Center/St. Anne Hospital, Brno, Czech Republic.
Teresa J ChristiansonDepartment of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Walter K KremersDepartment of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Ronald C PetersenDepartment of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Yonas E GedaDepartment of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.ORCID 0000-0003-1187-7230
Mayo Clinic · USMayo Clinic in Florida · USBarrow Neurological Institute · USKarlsruhe Institute of Technology · DEParacelsus Medical University · AT

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
Development, Validation, and Application of an Imaging based CVD ScaleR01NS097495 · NINDS · MAYO CLINIC ROCHESTER · PI VEMURI, PRASHANTHI · 2016 to 2020
$2.9M
Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ DementiaR01AG057708 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GEDA, YONAS E · 2018 to 2022
$1.7M
Psychiatric Characterization/Mild Cognitive ImpairmentK01MH068351 · NIMH · MAYO CLINIC ROCHESTER · PI GEDA, YONAS E · 2004 to 2008
$890k
NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG011378NIA NIH HHS R01 AG034676NIA NIH HHS R01 AG041851NIA NIH HHS R01 AG057708NIA NIH HHS U01 AG006786NIMH NIH HHS K01 MH068351NINDS NIH HHS R01 NS097495
6 · The paper itself

Abstract

introductionWe investigated the longitudinal relationship between cortical amyloid deposition, anxiety, and depression and the risk of incident mild cognitive impairment (MCI).

methodsWe followed 1440 community-dwelling, cognitively unimpaired individuals aged ≥ 50 years for a median of 5.5 years. Clinical anxiety and depression were assessed using Beck Anxiety and Depression Inventories (BAI, BDI-II). Cortical amyloid beta (Aβ) was measured by Pittsburgh compound B positron emission tomography (PiB-PET) and elevated deposition (PiB+) was defined as standardized uptake value ratio ≥ 1.48. We calculated Cox proportional hazards models with age as the time scale, adjusted for sex, education, and medical comorbidity.

resultsCortical Aβ deposition (PiB+) independent of anxiety (BAI ≥ 10) or depression (BDI-II ≥ 13) increased the risk of MCI. There was a significant additive interaction between PiB+ and anxiety (joint effect hazard ratio 6.77; 95% confidence interval 3.58-12.79; P = .031) that is, being PiB+ and having anxiety further amplified the risk of MCI. DISCUSSION: Anxiety modified the association between PiB+ and incident MCI.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloid beta-PeptidesAniline CompoundsAnxietyBrainDepressionHumansNeuropsychological TestsPositron-Emission TomographyAmyloid beta-PeptidesAniline Compoundsamyloid imaginganxietydepressionmild cognitive impairmentPittsburgh compound B positron emission tomography

Identifiers

PMID34877794
PMCPMC9174347
OpenAlexW4200564175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.